A citation-based method for searching scientific literature

Simeon I Taylor, Jenny E Blau, Kristina I Rother, Amber L Beitelshees. Lancet Diabetes Endocrinol 2019
Times Cited: 18







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2.
Sreeneeranj Kasichayanula, Xiaoni Liu, Frank Lacreta, Steven C Griffen, David W Boulton. Clin Pharmacokinet 2014
110
5

Antibody validation.
Jennifer Bordeaux, Allison Welsh, Seema Agarwal, Elizabeth Killiam, Maria Baquero, Jason Hanna, Valsamo Anagnostou, David Rimm. Biotechniques 2010
375
5

Salmon provides fast and bias-aware quantification of transcript expression.
Rob Patro, Geet Duggal, Michael I Love, Rafael A Irizarry, Carl Kingsford. Nat Methods 2017
5


Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes.
Amalia Gastaldelli, Enrico Repetto, Cristian Guja, Elise Hardy, Jenny Han, Serge A Jabbour, Ele Ferrannini. Diabetes Obes Metab 2020
16
6

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.
Elisa Vergari, Jakob G Knudsen, Reshma Ramracheya, Albert Salehi, Quan Zhang, Julie Adam, Ingrid Wernstedt Asterholm, Anna Benrick, Linford J B Briant, Margarita V Chibalina,[...]. Nat Commun 2019
49
5

SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?
John R Petrie. Lancet Diabetes Endocrinol 2017
7
14

Upgrading pretransplant human islet culture technology requires human serum combined with media renewal.
Julie Kerr-Conte, Brigitte Vandewalle, Ericka Moerman, Bruno Lukowiak, Valery Gmyr, Laurent Arnalsteen, Robert Caiazzo, Adrien Sterkers, Thomas Hubert, Marie Christine Vantyghem,[...]. Transplantation 2010
30
5

Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes.
Åsa Segerstolpe, Athanasia Palasantza, Pernilla Eliasson, Eva-Marie Andersson, Anne-Christine Andréasson, Xiaoyan Sun, Simone Picelli, Alan Sabirsh, Maryam Clausen, Magnus K Bjursell,[...]. Cell Metab 2016
464
5


Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism.
João Fadista, Petter Vikman, Emilia Ottosson Laakso, Inês Guerra Mollet, Jonathan Lou Esguerra, Jalal Taneera, Petter Storm, Peter Osmark, Claes Ladenvall, Rashmi B Prasad,[...]. Proc Natl Acad Sci U S A 2014
228
5

The biology of glucagon and the consequences of hyperglucagonemia.
Nicolai J Wewer Albrechtsen, Rune E Kuhre, Jens Pedersen, Filip K Knop, Jens J Holst. Biomark Med 2016
39
5

Opposing actions of Arx and Pax4 in endocrine pancreas development.
Patrick Collombat, Ahmed Mansouri, Jacob Hecksher-Sorensen, Palle Serup, Jens Krull, Gerard Gradwohl, Peter Gruss. Genes Dev 2003
353
5

Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody.
Daniela Balen, Marija Ljubojevic, Davorka Breljak, Hrvoje Brzica, Vilim Zlender, Hermann Koepsell, Ivan Sabolic. Am J Physiol Cell Physiol 2008
100
5


Diabetes and Hypertension: A Position Statement by the American Diabetes Association.
Ian H de Boer, Sripal Bangalore, Athanase Benetos, Andrew M Davis, Erin D Michos, Paul Muntner, Peter Rossing, Sophia Zoungas, George Bakris. Diabetes Care 2017
187
5

Metabolic health and vascular complications in type 1 diabetes.
Sandhya Bhattarai, Ian F Godsland, Shivani Misra, Desmond G Johnston, Nick Oliver. J Diabetes Complications 2019
1
100

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus.
D R Witte, S Tesfaye, N Chaturvedi, S E M Eaton, P Kempler, J H Fuller. Diabetologia 2005
111
5

Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - role for Rho-kinase activation.
Zsolt Bagi, Attila Feher, James Cassuto, Komala Akula, Nazar Labinskyy, Gabor Kaley, Akos Koller. Br J Pharmacol 2011
20
5

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.
Bryan Williams, Thomas M MacDonald, Steve Morant, David J Webb, Peter Sever, Gordon McInnes, Ian Ford, J Kennedy Cruickshank, Mark J Caulfield, Jackie Salsbury,[...]. Lancet 2015
466
5

Mechanisms of obesity-induced hypertension.
Vasilios Kotsis, Stella Stabouli, Sofia Papakatsika, Zoe Rizos, Gianfranco Parati. Hypertens Res 2010
275
5


Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study.
M Toeller, A Buyken, G Heitkamp, S Brämswig, J Mann, R Milne, F A Gries, H Keen. Diabetologia 1997
46
5

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.
Shona J Livingstone, Helen C Looker, Eleanor J Hothersall, Sarah H Wild, Robert S Lindsay, John Chalmers, Stephen Cleland, Graham P Leese, John McKnight, Andrew D Morris,[...]. PLoS Med 2012
169
5

Effect of 5-year enalapril therapy on progression of microalbuminuria and glomerular structural changes in type 1 diabetic subjects.
Jamal Ahmad, Sheelu Shafique, S M Abbas Abidi, Iqbal Parwez. Diabetes Res Clin Pract 2003
17
5

Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Linda F Fried, Nicholas Emanuele, Jane H Zhang, Mary Brophy, Todd A Conner, William Duckworth, David J Leehey, Peter A McCullough, Theresa O'Connor, Paul M Palevsky,[...]. N Engl J Med 2013
556
5

ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
David M Maahs, Janet K Snell-Bergeon, Gregory L Kinney, R Paul Wadwa, Satish Garg, Lorraine G Ogden, Marian Rewers. J Diabetes Complications 2007
18
5

Cellular and molecular mechanisms of endothelial dysfunction in diabetes.
Anna C Roberts, Karen E Porter. Diab Vasc Dis Res 2013
117
5

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Paul K Whelton, Robert M Carey, Wilbert S Aronow, Donald E Casey, Karen J Collins, Cheryl Dennison Himmelfarb, Sondra M DePalma, Samuel Gidding, Kenneth A Jamerson, Daniel W Jones,[...]. Hypertension 2018
5

Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study.
A R Andersen, J S Christiansen, J K Andersen, S Kreiner, T Deckert. Diabetologia 1983
646
5

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Dena Ettehad, Connor A Emdin, Amit Kiran, Simon G Anderson, Thomas Callender, Jonathan Emberson, John Chalmers, Anthony Rodgers, Kazem Rahimi. Lancet 2016
5

Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers.
Massimo Volpe, Allegra Battistoni, Giuliano Tocci, Enrico Agabiti Rosei, Alberico L Catapano, Rosanna Coppo, Stefano del Prato, Sandro Gentile, Elmo Mannarino, Salvatore Novo,[...]. J Hypertens 2012
51
5


Association between the dietary approaches to hypertension diet and hypertension in youth with diabetes mellitus.
Anke L B Günther, Angela D Liese, Ronny A Bell, Dana Dabelea, Jean M Lawrence, Beatriz L Rodriguez, Debra A Standiford, Elizabeth J Mayer-Davis. Hypertension 2009
88
5



Long-term comparison between perindopril and nifedipine in normotensive patients with type 1 diabetes and microalbuminuria.
G Jerums, T J Allen, D J Campbell, M E Cooper, R E Gilbert, J J Hammond, J Raffaele, C Tsalamandris. Am J Kidney Dis 2001
52
5

Early disturbances of ambulatory blood pressure load in normotensive type I diabetic patients with microalbuminuria.
P Y Benhamou, S Halimi, R De Gaudemaris, R Boizel, M Pitiot, J P Siche, I Bachelot, J M Mallion. Diabetes Care 1992
41
5

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
Connor A Emdin, Kazem Rahimi, Bruce Neal, Thomas Callender, Vlado Perkovic, Anushka Patel. JAMA 2015
351
5




Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus.
G E McVeigh, G M Brennan, G D Johnston, B J McDermott, L T McGrath, W R Henry, J W Andrews, J R Hayes. Diabetologia 1992
578
5

Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats.
M D Johnson, A Grignolo, C M Kuhn, S M Schanberg. Life Sci 1983
50
5

2018 ESC/ESH Guidelines for the management of arterial hypertension.
Bryan Williams, Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier, Denis L Clement, Antonio Coca, Giovanni de Simone, Anna Dominiczak,[...]. Eur Heart J 2018
5

Race/ethnic difference in diabetes and diabetic complications.
Elias K Spanakis, Sherita Hill Golden. Curr Diab Rep 2013
210
5

Diabetes and hypertension: the bad companions.
Ele Ferrannini, William C Cushman. Lancet 2012
253
5

Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.
Elizabeth J Mayer-Davis, Jean M Lawrence, Dana Dabelea, Jasmin Divers, Scott Isom, Lawrence Dolan, Giuseppina Imperatore, Barbara Linder, Santica Marcovina, David J Pettitt,[...]. N Engl J Med 2017
504
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.